Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancer

JOURNAL ARTICLE published October 2018 in Lung Cancer

Authors: Katsutoshi Sekine | Shintaro Kanda | Yasushi Goto | Hidehito Horinouchi | Yutaka Fujiwara | Noboru Yamamoto | Noriko Motoi | Yuichiro Ohe